NZ337927A - Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds - Google Patents
Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compoundsInfo
- Publication number
- NZ337927A NZ337927A NZ337927A NZ33792798A NZ337927A NZ 337927 A NZ337927 A NZ 337927A NZ 337927 A NZ337927 A NZ 337927A NZ 33792798 A NZ33792798 A NZ 33792798A NZ 337927 A NZ337927 A NZ 337927A
- Authority
- NZ
- New Zealand
- Prior art keywords
- tetrahydro
- benzoic acid
- tetramethyl
- naphthyloxy
- methyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Physical Vapour Deposition (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3560497P | 1997-03-24 | 1997-03-24 | |
| PCT/US1998/005591 WO1998042340A1 (en) | 1997-03-24 | 1998-03-24 | Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ337927A true NZ337927A (en) | 2000-11-24 |
Family
ID=21883695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ337927A NZ337927A (en) | 1997-03-24 | 1998-03-24 | Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1019049A1 (pt) |
| JP (1) | JP2001521551A (pt) |
| KR (1) | KR20010005678A (pt) |
| CN (1) | CN1256630A (pt) |
| AU (1) | AU6576398A (pt) |
| BR (1) | BR9808054A (pt) |
| CA (1) | CA2284192A1 (pt) |
| IL (1) | IL132032A0 (pt) |
| NO (1) | NO994612L (pt) |
| NZ (1) | NZ337927A (pt) |
| WO (1) | WO1998042340A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR023700A1 (es) * | 1998-11-12 | 2002-09-04 | Smithkline Beecham Plc | Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina |
| KR100643833B1 (ko) * | 1998-11-12 | 2006-11-10 | 스미스클라인비이참피이엘시이 | 인슐린 감작제 및 다른 항당뇨병 약제의 개선된 방출을위한 제약 조성물 |
| WO2002100396A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT |
| CN1921843A (zh) * | 2004-01-23 | 2007-02-28 | 独立行政法人科学技术振兴机构 | 含视黄酸的糖尿病治疗药 |
| US11191755B2 (en) | 2014-01-17 | 2021-12-07 | Cornell University | Compositions and methods for providing cardioprotective effects |
| CA2937107C (en) | 2014-01-17 | 2020-12-22 | Cornell University | Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04504847A (ja) * | 1989-03-08 | 1992-08-27 | ザ ユニバーシティ オヴ バージニア パテント ファウンデーション | インスリン抵抗性糖尿病のための食事用補添物 |
| FR2695317B1 (fr) * | 1992-09-07 | 1995-03-10 | Monal Lab | Composition apte à stimuler la sécrétion d'insuline destinée au traitement du diabète non insulino-dépendant. |
| AU676227B2 (en) * | 1993-01-22 | 1997-03-06 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Therapeutic agent for NIDDM |
| US5478852C1 (en) * | 1993-09-15 | 2001-03-13 | Sankyo Co | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus |
| US5444086A (en) * | 1994-03-31 | 1995-08-22 | American Home Products Corporation | Naphthalenylmethyl thiophenones as antihyperglycemic agents |
-
1998
- 1998-03-24 WO PCT/US1998/005591 patent/WO1998042340A1/en not_active Application Discontinuation
- 1998-03-24 KR KR1019997008746A patent/KR20010005678A/ko not_active Application Discontinuation
- 1998-03-24 AU AU65763/98A patent/AU6576398A/en not_active Abandoned
- 1998-03-24 CN CN98805131A patent/CN1256630A/zh active Pending
- 1998-03-24 BR BR9808054-7A patent/BR9808054A/pt not_active Application Discontinuation
- 1998-03-24 JP JP54585198A patent/JP2001521551A/ja active Pending
- 1998-03-24 NZ NZ337927A patent/NZ337927A/xx unknown
- 1998-03-24 EP EP98911919A patent/EP1019049A1/en not_active Withdrawn
- 1998-03-24 IL IL13203298A patent/IL132032A0/xx unknown
- 1998-03-24 CA CA002284192A patent/CA2284192A1/en not_active Abandoned
-
1999
- 1999-09-22 NO NO994612A patent/NO994612L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998042340A1 (en) | 1998-10-01 |
| JP2001521551A (ja) | 2001-11-06 |
| CA2284192A1 (en) | 1998-10-01 |
| NO994612L (no) | 1999-11-24 |
| KR20010005678A (ko) | 2001-01-15 |
| BR9808054A (pt) | 2000-11-07 |
| CN1256630A (zh) | 2000-06-14 |
| IL132032A0 (en) | 2001-03-19 |
| NO994612D0 (no) | 1999-09-22 |
| AU6576398A (en) | 1998-10-20 |
| EP1019049A1 (en) | 2000-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1121129B1 (en) | METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS | |
| KR100697582B1 (ko) | 케톤증 개선제 | |
| WO1998005331A3 (en) | Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators | |
| AU688739B2 (en) | Method and composition for the treatment of Parkinson's disease | |
| KR940006590A (ko) | 알쯔하이머 질환 치료용 및 혈당저하제로서 유용한 화합물 | |
| NO314065B1 (no) | Farmasöytisk sammensetning omfattende en insulinsensitivitetsenhancer og etbiguanid ved behandling av diabetes | |
| AU4291499A (en) | Pharmaceutical composition for the treatment of diabetes | |
| KR940019699A (ko) | 옥사졸리딘디온 유도체, 그의 제조방법 및 용도 | |
| MX9700763A (es) | Procedimiento para la preparacion de benzoxazoles y derivados de piridinas utiles en el tratamiento de la diabetes del tipo ii, los benzoxazoles y derivados de piridina obtenidos, composiciones de los mismos y su uso. | |
| EP0695183B1 (en) | Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders | |
| EP1078923A3 (en) | Process for the preparation of benzothiophene derivatives | |
| CA2397294A1 (en) | Glyburide composition | |
| NZ337927A (en) | Methods and compositions for treating and/or preventing non-insulin dependent diabetes mellitus (NIDDM) using specific retinoid compounds | |
| NO322314B1 (no) | Farmasoytisk preparat, sett som omfatter flere beholdere, samt anvendelse av troglitazon, pioglitazon og/eller BRL-49653 ved fremstilling av et medikament. | |
| IL112590A (en) | Insulin sensitisers for use in the treatment of renal diseases | |
| JP2002508373A5 (pt) | ||
| EP0921798A1 (en) | Novel treatment of leptine resistance | |
| AP1441A (en) | Hydrate of 5- [4-{2-(N-methlyl-N-(2-pyridil) amino) ethoxy} benzyl] thiazolidine-2,4-dione maleic acid salt. | |
| EP1405848A4 (en) | TETRAHYDROCHINOLINE DERIVATIVE COMPOUND AND THE COMPOUND OF AN ACTIVE MEDICAMENT CONTAINING ACTIVE SUBSTANCE | |
| NZ513922A (en) | Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione | |
| JPS62132826A (ja) | 抗高血圧剤 | |
| IE871766L (en) | 4-(aroylamino)piperidinebutanamide derivatives | |
| CO4940489A1 (es) | Nuevo metodo de tratamiento cines asociadas a la misma en mamiferos | |
| BG103966A (bg) | Лечение на диабет с тиазолидиндион и инхибитор наалфа глюкозидазата | |
| RU99122356A (ru) | Родственные ретиноиду молекулы для лечения инсулиннезависимого сахарного диабета |